Differing Approaches to Biomedical Research
In order to study different approaches to research, one might visit scientists working in an intramural laboratory at the National Institutes of Health (NIH), scientists of similar kind in an academic medical center, and others of the same discipline in a laboratory of a pharmaceutical firm. One would initially find little to write about. The physical settings and the instrumentation inside the laboratories would be similar. The kinds of people milling about, their jargon, the smells, and the sounds would be indistinguishable in going from one laboratory to another. If, however, the visits allowed one enough time to see how each of the scientists spends his or her time over the course of several days, one would begin to see important differences, differences reflecting the missions and philosophies of the respective parent institutions as well as the missions and philosophies of the financial supporters of the research being undertaken by each of the scientists.
KeywordsPharmaceutical Industry Biomedical Research Academic Medical Center Pharmaceutical Firm Industrial Laboratory
Unable to display preview. Download preview PDF.
- Goldberg, L. I., 1980, An academic investigator’s view of collaboration with industry, Perspect. Biol. Med. 23(2, part 2):S89–S91.Google Scholar
- Helms, R. B. (ed.), 1981, Drugs and Health: Economic Issues and Policy Objectives, American Enterprise Institute for Public Policy Research, Washington and London.Google Scholar
- Industry and the universities: Developing cooperative research relationships in the national interest. Report of the National Commission on Research to the 42nd Meeting of the Advisory Committee to the Director, MH, March 16–17, 1981, Bethesda, Maryland.Google Scholar
- Kass, E. H., 1980, Factors affecting research support and career decisions in clinical investigation, Perspect. Biol Med. 23(2, part 2):S44–S52.Google Scholar
- Schneyer, S., 1981, You can plan to look for gold, but you can’t plan to find it: Comprehensive planning for health research revisited, Clin. Res. 29(2):95–100.Google Scholar
- Stetten, D., Jr., 1980, Research in a no-growth economy—can excellence be preserved?, Perspect. Biol. Med. 23(3):357–369.Google Scholar
- Swisher, S. N., 1980, Manpower training for fundamental clinical research, Perspect. Biol. Med. 23(2, part 2):S62–S78.Google Scholar
- 1.Fredrickson, D. S., 1978, The National Institutes of Health: Yesterday, today, and tomorrow, Public Health Rep. 93(6):642–647.Google Scholar
- 2.Grabowski, H. G., and Vernon, J., 1981, The determinants of research and development expenditures in the pharmaceutical industry, in: Drugs and Health: Economic Issues and Policy Objectives (R. B. Helms, ed.), American Enterprise Institute for Public Policy Research, Washington and London, pp. 3–20.Google Scholar
- 3.Undenfriend, S., 1980, Improving the scientific base of clinical research by facilitating collaboration among academia, the pharmaceutical industry, and government, Perspect. Biol. Med. 23(2, part 2):S83–S88.Google Scholar
- 4.Nelson, A. J., 1980, Regulator encumbrances to pharmaceutical research, Perspect. Biol. Med. 23(2, part 2):S150–S153.Google Scholar